- Home
- IMMX vs GROV Comparison
IMMX vs GROV Comparison
Compare IMMX & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- GROV
- Stock Information
- Founded
- IMMX 2014
- GROV 2016
- Country
- IMMX United States
- GROV United States
- Employees
- IMMX N/A
- GROV N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- GROV Package Goods/Cosmetics
- Sector
- IMMX Health Care
- GROV Consumer Discretionary
- Exchange
- IMMX Nasdaq
- GROV Nasdaq
- Market Cap
- IMMX 51.1M
- GROV 51.9M
- IPO Year
- IMMX 2021
- GROV N/A
- Fundamental
- Price
- IMMX $1.45
- GROV $1.29
- Analyst Decision
- IMMX Strong Buy
- GROV Buy
- Analyst Count
- IMMX 1
- GROV 1
- Target Price
- IMMX $7.00
- GROV $2.00
- AVG Volume (30 Days)
- IMMX 145.3K
- GROV 173.4K
- Earning Date
- IMMX 11-11-2024
- GROV 11-07-2024
- Dividend Yield
- IMMX N/A
- GROV N/A
- EPS Growth
- IMMX N/A
- GROV N/A
- EPS
- IMMX N/A
- GROV N/A
- Revenue
- IMMX N/A
- GROV $227,251,000.00
- Revenue This Year
- IMMX N/A
- GROV N/A
- Revenue Next Year
- IMMX $200.00
- GROV $5.97
- P/E Ratio
- IMMX N/A
- GROV N/A
- Revenue Growth
- IMMX N/A
- GROV N/A
- 52 Week Low
- IMMX $1.26
- GROV $1.19
- 52 Week High
- IMMX $7.75
- GROV $2.49
- Technical
- Relative Strength Index (RSI)
- IMMX 39.98
- GROV 45.73
- Support Level
- IMMX $1.26
- GROV $1.26
- Resistance Level
- IMMX $1.80
- GROV $1.33
- Average True Range (ATR)
- IMMX 0.16
- GROV 0.09
- MACD
- IMMX 0.00
- GROV -0.00
- Stochastic Oscillator
- IMMX 35.19
- GROV 21.43
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.